您当前所在位置:首页 > 资讯信息 > 新品上市
序号 标题 次数 作者 发布时间
76816 cas:141534-26-1,2-(4-formylbenzamido)ethyl nitrate 169 wyh 2024-12-19
76817 cas:159857-81-5 Mc-Val-Cit-PABC-PNP 117 zyl 2024-12-19
76818 MC-PEG4-va-PAB-Exatecan, ADC试剂 178 kx 2024-12-19
76819 cas:2101206-44-2 PY-DS-DMBUT-OPFP 131 zyl 2024-12-19
76820 Perfluorophenyl 3-(2-(2-(4-formylbenzamido)ethoxy)ethoxy)propanoate 73 wyh 2024-12-19
76821 SMCC-DM4(CAS号:1228105-52-9) 106 WYQ 2024-12-19
76822 NHS ester-PEG4-VC-PAB-Dxd, ADC试剂 257 kx 2024-12-19
76823 cas:53053-08-0,4-azidobenzoic acid N-hydroxysuccinimide ester 85 wyh 2024-12-19
76824 N3-Linker-Gefitinib,Gefitinib本身具有*肿瘤活性 130 WYQ 2024-12-19
76825 Boc-Val-Cit-OH的介绍 107 zyl 2024-12-19
76826 mDPR-Val-Ala-PAB-MMAE, ADC试剂 127 kx 2024-12-19
76827 Boc-Val-Ala-PAB-OC2H5 | ADC Linker 115 zyl 2024-12-19
76828 cas:2259318-56-2,DBCO-PEG4-VC-PAB-DMAE-PNU159682, ADC试剂 119 kx 2024-12-19
76829 Mc-Dexamethasone,CAS号:1618096-56-2 132 WYQ 2024-12-19
76830 N3-PEG4-YPYDVPDYA-Doxorubicin,抗体偶联药物(ADC)的一部分 156 WYQ 2024-12-19
76831 DBCO-PEG4-VA-PAB-EDA-N-Ac-Calicheamicin,ADC定制 163 kx 2024-12-19
76832 N3-PEG4-DYKDDDD-Doxorubicin,抗体偶联药物(ADC)的一部分 132 WYQ 2024-12-19
76833 Azide-hex-vc-PAB-EDA-Biotin的介绍 137 zyl 2024-12-19
76834 Fmoc-PEG4-Val-Ala-PAB-PNP,具有类似的可降解性、生物相容性和定向运输特性 143 WYQ 2024-12-19
76835 DBCO-PEG4-vc-PAB (PEG2)- Duocarmycin SA,ADC定制 137 kx 2024-12-19
76836 Mal-Ala-Ala-PAB-PNP的介绍 167 zyl 2024-12-19
76837 Fmoc-PEG4-Val-Ala-PAB,合成抗体偶联药物(ADC) 109 WYQ 2024-12-19
76838 BODIPY-erythromycin,ADC定制 145 kx 2024-12-19
76839 MA-PEG4-Glu-Val-Cit-PAB-PNP 129 zyl 2024-12-19
76840 Boc-PEG4-Val-Ala-PAB-PNP,用于合成抗体偶联药物(ADC) 101 WYQ 2024-12-19
76841 Mc-Phe-Lys(Boc)-PAB-ADC分子 135 zyl 2024-12-19
76842 MC-GGFG-Dxd, ADC试剂 549 kx 2024-12-19
76843 Fmoc-Arg(boc)2-PAB-PNP-ADC抗体偶联药物 102 zyl 2024-12-19
76844 DBCO-PEG4-AcBu-Calicheamicin, ADC试剂 92 kx 2024-12-19
76845 Azido-PEG4-Val-Ala-PAB的介绍 90 zyl 2024-12-19
76846 2,5-dioxopyrrolidin-1-yl 3-(2-(2-(2-(cyclooct-2-ynyloxy)acetamido)ethoxy)ethoxy)propanoate,ADC定制 74 wyh 2024-12-19
76847 OH-Glu-VC-PAB-MMAE, ADC试剂 148 kx 2024-12-19
76848 cas:663599-10-8,2,5-dioxopyrrolidin-1-yl 4-((3-(dimethylcarbamoyl)pyridin-4-yl)disulfanyl)pentanoate,ADC定制 93 wyh 2024-12-19
76849 GGVA-PAB-PNU, ADC试剂 129 kx 2024-12-19
76850 132178-37-1,4-戊炔酸琥珀亚胺酯,ADC定制 196 wyh 2024-12-19
76851 cas:863971-53-3 Fmoc-Val-Cit-PAB-PNP 82 zyl 2024-12-19
76852 N3-PEG4-vc-PAB-Doxorubicin,药物递送系统的一部分 135 WYQ 2024-12-19
76853 cas:55750‐61‐3,N-SMP,马来酰亚胺基乙酸琥珀酰亚胺酯,ADC定制 108 wyh 2024-12-19
76854 MC-PEG4-EDA-PNU, ADC试剂 135 kx 2024-12-19
76855 cas:2055024-54-7 Boc-PEG4-Val-Cit-PAB-OH 129 zyl 2024-12-19
76856 Fmoc-PEG3-Ala-Ala-Asn(Trt)-PAB-PNP(CAS: 2055042-82-3) 119 WYQ 2024-12-19
76857 Mal-amido-PEG8-val-gly-PAB-OH(CAS: 2353409-52-4) 117 WYQ 2024-12-19
76858 cas:160854-54-6,4-succinimidyl-oxycarbonyl-α-(2-pyridyldithio)toluene,ADC定制 104 wyh 2024-12-19
76859 cas:2504147-59-3 MC (C5)-Val-Cit 143 zyl 2024-12-19
76860 Boc-PEG4-Val-Ala-PAB,可降解的ADC连接体 152 WYQ 2024-12-19
库存查询